Interestingly, GM-CSF is reported to either suppress or promote tumor progression (Hong, 2016; Kumar et al., 2022), necessitating a deeper understanding of the conditions in which this growth factor mediates beneficial versus detrimental functions during cancer therapy. This evidence concerns the gene CSF2 and neoplasm.